We are live on ! Find out more
KPF

K2 Principal Fund Portfolio holdings

AUM $1.43B
1-Year Est. Return 29.56%
This Fund
S&P 500
This Quarter Est. Return
+4.1%
1 Year Est. Return
+29.56%
3 Year Est. Return
+71.66%
5 Year Est. Return
+57.43%
10 Year Est. Return
+278.66%
AUM
$1.2B
AUM Growth
-$62.4M
Cap. Flow
-$305M
Cap. Flow %
-25.32%
Top 10 Hldgs %
18.47%
Holding
522
New
224
Increased
59
Reduced
21
Closed
158

Sector Composition

Rank Sector Weight
1 Financials 14.93%
2 Healthcare 6.9%
3 Consumer Discretionary 4.69%
4 Real Estate 4.09%
5 Technology 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMPO
76
DELISTED
Tempo Automation Holdings, Inc. Common Stock
TMPO
$4.08M 0.34%
410,178
+360,342
+723% +$3.6M
TLND
77
DELISTED
Talend S.A. American Depositary Shares
TLND
$4.04M 0.34%
61,608
+39,868
+183% +$2.58M
BRIVU
78
DELISTED
B. Riley Principal 250 Merger Corp. Units
BRIVU
$3.98M 0.33%
+400,000
New +$3.99M
GRA
79
DELISTED
W.R. Grace & Co.
GRA
$3.72M 0.31%
53,878
+41,878
+349% +$2.82M
SII
80
Sprott
SII
$2.68B
$3.38M 0.28%
+86,005
New +$3.7M
EWJ icon
81
CALL
iShares MSCI Japan ETF
EWJ
$21.7B
$3.38M 0.28%
50,000
LEV
82
DELISTED
The Lion Electric Company
LEV
$3.36M 0.28%
+182,000
New +$3.41M
PKBO
83
DELISTED
Peak Bio, Inc. Common Stock
PKBO
$3.33M 0.28%
344,328
+200,892
+140% +$1.96M
GCMGW
84
CALL
DELISTED
GCM Grosvenor Inc Warrant
GCMGW
$3.33M 0.28%
+2,162,099
New +$3.51M
ONMD icon
85
OneMedNet
ONMD
$35.3M
$3.32M 0.28%
+335,408
New +$3.33M
OBIO icon
86
Orchestra BioMed
OBIO
$229M
$3.27M 0.27%
320,349
+255,443
+394% +$2.64M
COOP
87
CALL
DELISTED
Mr. Cooper
COOP
$3.27M 0.27%
98,800
-56,200
-36% -$1.88M
ADVM
88
DELISTED
Adverum Biotechnologies
ADVM
$3.14M 0.26%
+89,831
New +$4.84M
THCA
89
DELISTED
Tuscan Holdings Corp. II Common Stock
THCA
$3.14M 0.26%
312,362
KWAC
90
DELISTED
Kingswood Acquisition Corp.
KWAC
$3.13M 0.26%
+311,487
New +$3.12M
LAAAU
91
DELISTED
Lakeshore Acquisition I Corp. Unit
LAAAU
$3.07M 0.25%
+300,000
New +$3.02M
FTVIU
92
DELISTED
FinTech Acquisition Corp. VI Units
FTVIU
$3.03M 0.25%
+300,000
New +$3.03M
ATH
93
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$3.01M 0.25%
44,569
+10,221
+30% +$615K
OTECU
94
DELISTED
OceanTech Acquisitions I Corp. Units
OTECU
$3M 0.25%
+300,000
New +$3M
CLDR
95
DELISTED
Cloudera, Inc.
CLDR
$2.98M 0.25%
+187,763
New +$2.55M
AFAQ
96
DELISTED
AF Acquisition Corp
AFAQ
$2.93M 0.24%
+300,000
New +$2.92M
CIT
97
DELISTED
CIT Group Inc.
CIT
$2.91M 0.24%
56,477
+11,688
+26% +$614K
ESM
98
DELISTED
ESM Acquisition Corporation
ESM
$2.9M 0.24%
+300,000
New +$2.92M
ACIC
99
DELISTED
Atlas Crest Investment Corp.
ACIC
$2.89M 0.24%
+289,721
New +$2.88M
CBB
100
DELISTED
Cincinnati Bell Inc.
CBB
$2.88M 0.24%
186,526

Similar funds

K2 Principal Fund's Q2 2021 Portfolio in Review

As of Q2 2021, K2 Principal Fund held 522 positions worth $1.2B, down 4.9% from $1.27B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

K2 Principal Fund withdrew a net $305M in Q2 2021, closing 158 positions and reducing 21 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $9.52M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, K2 Principal Fund opened a new position in Global Consumer Acquisition Corp. Unit worth $12.2M.

  • K2 Principal Fund's largest Q2 2021 buy was Global Consumer Acquisition Corp. Unit: 1,225,489 shares worth $12.2M.
  • K2 Principal Fund added most to SkinHealth Systems in Q2 2021, an estimated $10.3M increase.
  • K2 Principal Fund's biggest Q2 2021 reduction was PennyMac Financial, cutting an estimated $20.4M.
  • K2 Principal Fund fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $9.52M.
  • K2 Principal Fund's ten largest holdings make up 18% of its $1.2B portfolio in Q2 2021.
  • K2 Principal Fund opened 224 new positions and closed 158 in Q2 2021.
  • K2 Principal Fund's portfolio value fell 4.9% quarter-over-quarter to $1.2B.

Based on K2 Principal Fund's 13F filing for Q2 2021, filed 13 Aug 2021.